Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | DGKZ | Q13574 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20569040 | 1.00 | L3MBTL1 (0.40) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL20569443 | 1.00 | L3MBTL1 (0.40) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL24658819 | 1.00 | L3MBTL1 (0.40) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL23055169 | 0.83 | ALDH1A1 (0.41) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL23055156 | 0.82 | DGKZ (0.43) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL23055178 | 0.81 | DGKZ (0.42) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL28750693 | 0.81 | DGKZ (0.42) | L3MBTL1CA12CA1CA2CA9 | |
| SCHEMBL24658820 | 0.78 | RXRA (0.39) | L3MBTL1CA1CA2CA9ALDH1A1 | |
| SCHEMBL20572276 | 0.76 | MAPT (0.46) | PKMMAPTALDH1A1 | |
| SCHEMBL20572278 | 0.76 | MAPT (0.46) | PKMMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022173756-A1 | ANTIBACTERIAL COMPOUNDS | FORGE THERAPEUTICS, INC. (US) | 2022-08-18 | — | — | WO | disclosed |
| WO-2018216822-A1 | NOVEL IMIDAZOLE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2018-11-29 | — | — | WO | disclosed |